Skip to Main Content

Paper Details

Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy.
Nutrition and Metabolism
11
2019
Acylcarnitines, C3DC, CKD, IgA, IgA nephropathy, IgAN, acylcarnitines, chronic kidney disease, patients, short
Author NameAffiliation
Rong ZengInstitute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Yueyi DengLonghua Hospital, Shanghai University of Traditional Chinese Medicine
  • 1 - 2

Datasets

Release 1.2